Cite
Garrido-Abad P, Senra-Bravo I, Manfredi C, et al. Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study. Int J Impot Res. 2021;doi: 10.1038/s41443-020-00400-9.
Garrido-Abad, P., Senra-Bravo, I., Manfredi, C., Fernández-Pascual, E., Linares-Espinós, E., Fernández-Arjona, M., Varillas-Delgado, D., & Martínez-Salamanca, J. I. (2021). Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study. International journal of impotence research, . https://doi.org/10.1038/s41443-020-00400-9
Garrido-Abad, Pablo, et al. "Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study." International journal of impotence research vol. (2021). doi: https://doi.org/10.1038/s41443-020-00400-9
Garrido-Abad P, Senra-Bravo I, Manfredi C, Fernández-Pascual E, Linares-Espinós E, Fernández-Arjona M, Varillas-Delgado D, Martínez-Salamanca JI. Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study. Int J Impot Res. 2021 Jan 22; doi: 10.1038/s41443-020-00400-9. Epub 2021 Jan 22. PMID: 33483603.
Copy
Download .nbib